外体源非编码RNA的进展和挑战,用于肝细胞癌诊断和治疗
Min Shi1, Jun-Su Jia1, Guo-Sheng Gao1
1Department of Clinical Laboratory, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
Biochemistry and biophysics reports
|April 1, 2024
概括
外体,肝细胞癌 (HCC) 中的微小囊泡,携带非编码RNA (ncRNA),对瘤生长和扩散至关重要. 这些外体的ncRNAs显示出作为HCC诊断和治疗策略的生物标志物的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 外体 (细胞外囊泡) 是肝细胞癌 (HCC) 瘤微环境 (TME) 中的关键参与者.
- 外体介导的传播显著影响HCC瘤的发生和进展.
- 外基因源非编码RNAs (ncRNAs) 涉及HCC发育,免疫逃避和治疗耐药性.
研究的目的:
- 审查最近关于外体在HCC进展中的作用的发现.
- 分析外体衍生的ncRNA与HCC诊断和治疗之间的关系.
- 突出外体ncRNAs作为HCC中的生物标志物和治疗点的潜力.
主要方法:
- 对HCC中的外体和ncRNA研究的文献综述.
- 对外体提取和分子分析技术 (超离心,大小排除,测序) 的分析.
- 对特定外体ncRNAs (例如,miR-21-5p,miR-221-3p,lncRNA-ATB) 和它们在HCC中的功能进行数据综合.
主要成果:
- 外体ncRNAs被保护免受降解,确保诊断和预后应用的稳定性.
- 特定的外体ncRNAs (例如,miR-23a,DLX6-AS1,TUC339) 可以通过调节M2巨分离来调节免疫微环境,促进HCC.
- 外体ncRNAs的失调影响HCC的进展和治疗反应.
结论:
- 外体衍生的ncRNAs是HCC诊断和预后的有价值的生物标志物.
- 调节外体生物发生和外体ncRNA水平为HCC提供了潜在的治疗策略.
- 向外体ncRNAs为抑制或消除HCC提供了一个有希望的途径.
更多相关视频
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.1K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
相关概念视频
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K